Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIQUID BIOPSY IN Low-grade Glioma Patients
NCT05133154Active, not recruiting
- Sponsor
- CHU Montpellier
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Trial (3 arms), sponsored by CHU Montpellier. Primary endpoint: Proportion of patients with Circulating Tumor Cells (>0). Started Jan 2022; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05133154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05133154.